Welcome Guest
Sign In
Register
Home
Analytical Testing
Clinical Trials
Contract Research
Logistics
Manufacturing
Articles
Facility Tours
News
Events
Videos
Clinical Trials Documentary
A Solid Dosage Future Documentary
Whitepapers/App Notes
Issue Archives
Company Focus
Service Directory
Register
Sign In
Home
Clinical Trials
Product and Service Directory
Pharmaceutical Testing
Pharmaceutical Physical Testing Products and Services
Pharmaceutical Dissolution Testing Products and Services
Pharmaceutical Dissolution Testing Products and Services
Dissolution testing allows for the examination and prediction of the in-vitro behavior of pharmaceutical formulations. Drug release behavior of pre-formulations is made possible by the use of specialized dissolution equipment. By dissolution testing, a researcher can simulate the behavior of capsule, bead, and enteric-coated tablets in-vitro.
Important Applications of Dissolution Testing
Quality Control
Replicating certain mechanisms of in-vitro drug release
Determining if drug behavior meets regulatory standards
Dissolution simulation when choosing pharmaceutical excipients
Examples of Pharmaceutical Dissolution Equipment
Paddle apparatus dissolution testing is used to simulate tablet behavior in the gastrointestinal tract. The release behavior of implants and transdermal medications can also be tested with dissolution equipment. The reciprocating cylinder dissolution apparatus ("Bio-Dis") is excellent for examining the dissolution behavior of extended release products. Dissolution analysis is key in determining the homogeneity of the final pharmaceutical product. Whether controlled by the bench user or fully automated, the implementation of a dissolution testing protocol is crucial in the final stages of drug development to ensure the efficacy, safety, and marketability of the final compound.
Pharmaceutical Dissolution Testing Products and Services
Pharmaceutical Dissolution Testing Services
Pharmaceutical Solubility Testing and Enhancement Services
News
The Next Test for AI in Pharmacovigilance Is Trust, Not Accuracy
Monday, September 21, 2026
An AI model can be right and still not be trusted. That’s what Bristol Myers Squibb (BMS) found six months into rolling out AI-powered adverse event processing: while F1 performance scores were tracking upward, the audit trail found reviewers still reopening cases the system had already cleared.
read more
Rethinking Early-Phase Outsourcing
Monday, September 21, 2026
The CDMOs that bridge the fulfilment gap and truly become partners are likely the best choice for biotechs and pharma looking to develop their early-stage asset. While most CDMOs are well-versed in providing services with regular communication, sharing strategic objectives with clients, and ...
read more
Horizon Lines: A Quarterly Review of NDAs – April to June 2026
Monday, September 21, 2026
This quarterly review on New Drug Applications contains data for applications approved for the first time during the second quarter of 2026, which includes New Molecular Entities (NMEs) and new biologics.
read more
The Human Advantage in ADME Testing
Friday, September 18, 2026
Animal models do not accurately recapitulate several aspects of human physiology, and these differences lead to variations in drug behaviors across species. Each contributes useful evidence, but what is missing is the connected human biology needed to predict ADME behavior with confidence.
read more
Upperton Receives MHRA License for Sterile Manufacturing Facility
Thursday, September 17, 2026
Upperton has received approval from the U.K. Medicines and Healthcare products Regulatory Agency for a variation to its Manufacturing and Importation Authorisation for Investigational Medicinal Products license covering a new sterile manufacturing facility in Nottingham.
read more
More News
Featured Videos
Pharma Flash - Biopharm Facility News and Regulatory Updates in this Week’s ...
Check out the top pharma news of the week from our Editor-In-Chief, Mike Auerbach. Watch video: Eli Lilly Chooses Vendor for Single-Use Facility and FDA Approves OTC oral contraceptive plus more news in this week’s Pharma Flash
Pharma Flash - Berkshire Sterile Add Lyo Capacity and Amneal Gets CRL from FDA
The hottest news – brought to you quickly – watch this week’s episode of the Pharma Flash
More Videos
Featured Products and Services
We're sorry, no matching articles were found. Please select different filter options and try your search again.
More Featured Products
Featured Articles
We're sorry, no matching articles were found. Please select different filter options and try your search again.
Subscriptions
Get started here for your complimentary print or digital subscription
Sign up Now »